Furthermore, researchers have discovered that the adaptive metabolism of tumor-infiltrating TI-Tregs in the TME could serve as a potential target for cancer therapy due to their ability to enhance ATP production under hypoxic conditions through FOXP3-induced OXPHOS (214). The gene discussed is FOXP3; the disease is neoplasm.